Adam M. Veness, VP, General Counsel and Secretary at ACCELERON PHARMA INC (XLRN), sold 1,309 shares at $52.83 ($68K) on 2020-01-02, disclosed to the SEC on 2020-01-03.
Scheduled sale ($68k) by VP, General Counsel and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.83 | 434 | $23K | 33.8% |
| 2 | $51.23 | 875 | $45K | 66.2% |
| Total | $51.76 avg | 1,309 | $68K | 100% |
| Filing → |
| XLRN | SELL | 2021-09-22 | $2.0M | — | Filing → |
| XLRN | SELL | 2021-09-09 | $184K | — | Filing → |
| XLRN | SELL | 2021-01-06 | $252K | — | Filing → |